Table 3.

Therapeutic effect(s) of contextual factors (n = 1,112).

Clinical conditions	Psychological and physiological n (%); 95%CI	Psychological n (%); 95%CI	Physiological n (%); 95%CI	No benefit n (%); 95%CI
Acute pain	640 (57.5); 54.6–60.5	210 (18.9); 16.6–21.3	132 (11.9); 10.1–13.9	130 (11.7); 9.9–13.8
Chronic pain	629 (56.6); 53.6–59.5	244 (21.9); 19.6–24.5	123 (11.1); 9.3–13.1	116 (10.4); 8.7–12.4
Cognitive disorder	227 (20.4); 18.1–22.9	616 (55.4); 52.4–58.3	65 (5.8); 4.6–7.4	204 (18.3); 16.1–20.8
Emotional disorder	336 (30.2); 27.5–33.0	689 (62.0); 59.0–64.8	50 (4.5); 3.4–5.9	37 (3.3); 2.4–4.6
Gastrointestinal problem	367 (33.0); 30.3–35.9	134 (12.0); 10.2–14.1	451 (40.6); 37.7–43.5	160 (14.4); 12.4–16.6
Sexual problem	505 (45.4); 42.5–48.4	336 (30.2); 27.5–33.0	99 (8.9); 7.3–10.8	172 (15.5); 13.4–17.8
Drug and medication addiction	283 (25.4); 22.9–28.1	258 (23.2); 20.8–25.8	40 (3.6); 2.6–4.9	531 (47.8); 44.8–50.7
Neurological problem	471 (42.4); 39.4–45.3	244 (21.9); 19.6–24.5	198 (17.8); 15.6–20.2	199 (17.9); 15.7–20.3
Rheumatologic problem	452 (40.6); 37.7–43.6	251 (22.6); 20.2–25.2	257 (23.1); 20.7–25.7	152 (13.7); 11.7–15.9
Immune/allergic problem	227 (20.4); 18.1–22.9	150 (13.5); 11.6–15.7	169 (15.2); 13.2–17.5	566 (50.9); 47.9–53.9
Oncological problem	310 (27.9); 25.3–30.6	513 (46.1); 43.2–49.1	74 (6.6); 5.3–8.3	215 (19.3); 17.1–21.8
Cardiovascular problem	297 (26.7); 24.1–29.4	185 (16.6); 14.5–19.0	405 (36.4); 33.6–39.3	225 (20.2); 17.9–22.7
Infectious problem	191 (17.2); 15.0–19.5	125 (11.2); 9.5–13.3	167 (15.0); 13.0–17.3	629 (56.6); 53.6–59.5
Insomnia	562 (50.5); 47.6–53.5	413 (37.1); 34.3–40.1	50 (4.5); 3.4–5.9	87 (7.8); 6.3–9.6

%, percentage; n, number of participants; 95%CI, 95% confidence interval.